MAM
Indiassetz appoints Ramakrishna Bhagavan as chief business officer
Mumbai: Real estate wealth management platform Indiassetz has appointed Ramakrishna Bhagavan as chief business officer.
Ramki, as he is popularly known, is a consumer banking veteran with extensive expertise in the retail domain across geographies in both domestic and international markets.
“Ramki has an impeccable track record of leadership and range of business skills that we believe are essential for heading the business at Indiassetz. In 2022, our key focus will be on extending the company’s customer base,” stated Indiassetz CEO Shivam Sinha. “Ramki’s considerable experience in global business, strategic collaborations, and managing massive distribution networks will be beneficial to Indiassetz’s NRI and HNI clientele. Ramki has vast leadership expertise and a track record of building successful organisations and enterprises. Ramki will play a critical role in the development of new growth platforms as Indiassetz’s chief business officer.”
In his earlier roles, Ramki has worked with top Indian banking institutions such as HSBC, Kotak and IDFC First. Prior to joining Indiassetz, he was with Maubank as the head of retail, SME and wealth divisions in Mauritius.
“I am ecstatic to be a part of a company that is redefining real estate investing and assisting clients in maximising the efficiency of their portfolio in India. I am confident that my contribution to Indiassetz will help the company grow in both the Indian and global markets,” said Ramakrishna Bhagavan on his new role.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
